| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | SVP, CSO, GLOBAL RESEARCH | Common Stock, $0.01 par value | 107K | $19.2M | $178.99 | 28 Feb 2024 | Direct |
| AbbVie Inc. | SVP, CSO, GLOBAL RESEARCH | Option (Right to Buy) | 18.9K | $2.73M | $144.54 | 15 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | 28 Feb 2024 | 1 | -$3.69M | 4 | SVP, CSO, GLOBAL RESEARCH | 01 Mar 2024, 17:50 |
| ABBV | AbbVie Inc. | 15 Feb 2024 | 5 | $0 | 4 | SVP, CSO, GLOBAL RESEARCH | 20 Feb 2024, 17:15 |
| ABBV | AbbVie Inc. | 28 Feb 2023 | 1 | -$4.31M | 4 | SVP, R&D AND CSO | 02 Mar 2023, 15:35 |
| ABBV | AbbVie Inc. | 16 Feb 2023 | 5 | $0 | 4 | SVP, R&D AND CSO | 21 Feb 2023, 17:07 |
| ABBV | AbbVie Inc. | 25 Feb 2022 | 1 | -$2.01M | 4 | SVP, R&D and CSO | 01 Mar 2022, 17:09 |
| ABBV | AbbVie Inc. | 17 Feb 2022 | 5 | $0 | 4 | SVP, R&D and CSO | 22 Feb 2022, 16:33 |